Document is current
Any future updates will be listed below
-
Authors
Duerksen, D.R. https://orcid.org/0000-0002-6744-2722
Lix, L.M.
Johansson, H.
McCloskey, E.V.
Harvey, N.C.
Kanis, J.A. https://orcid.org/0000-0002-3129-4326
Leslie, W.D. https://orcid.org/0000-0002-1056-1691
- License Information
-
More Information
Article History
Received: 8 June 2020
Accepted: 29 July 2020
First Online: 3 August 2020
Compliance with ethical standards
:
: Donald Duerksen: Nothing to declare in the context of this paper but has served as a consultant for Takeda and Abbvie.Lisa Lix: No conflicts of interest.Helena Johansson: No conflicts of interest.Eugene McCloskey: Nothing to declare for the context of this paper, but numerous ad hoc consultancies/speaking honoraria and/or research funding from Amgen, Bayer, General Electric, GSK, Hologic, Lilly, Merck Research Labs, Novartis, Novo Nordisk, Nycomed, Ono, Pfizer, ProStrakan, Roche, Sanofi-Aventis, Servier, Tethys, UBS, and Warner-Chilcott.Nicholas Harvey: Nothing to declare for the context of this paper, but has received consultancy/lecture fees/honoraria/grant funding from Alliance for Better Bone Health, Amgen, MSD, Eli Lilly, Servier, Shire, Consilient Healthcare, Radius Health, UCB, Kyowa Kirin, and Internis Pharma.John A. Kanis: Nothing to declare in the context of this paper. Has received grants from Amgen, Lilly, and Radius Health.William Leslie: No conflicts of interest.
: This study was approved by the University of Manitoba Research Ethics Board.
: This was a database study and therefore not applicable.
: This was a database study and therefore not applicable.
